Correlation Engine 2.0
Clear Search sequence regions


  • cytokines (2)
  • factor (1)
  • humans (1)
  • IL 1 (1)
  • IL- 1RAcP (1)
  • IL- 33 (7)
  • isomers (1)
  • MAPKs (1)
  • metastasis (1)
  • NF kappa B (2)
  • NF κB (1)
  • receptor (1)
  • signals (1)
  • ST2 (1)
  • Sizes of these terms reflect their relevance to your search.

    Interleukin-33 (IL-33) is a new member of the IL-1 cytokine family which plays roles in the nucleus as a nuclear factor and is released by damaged or necrotic cells to act as a cytokine. It can be released via damaged or necrotic cells and functions as a cytokine. The released IL-33 activates the downstream NF-κB and MAPKs signaling pathways through the isomers of the specific receptor ST2 and the interleukin-1 receptor accessory protein (IL-1RAcP), resulting in danger signals and the activated multiple immune responses. IL-33 is abnormally expressed in various tumors and involves in tumorigenesis, development, and metastasis. Moreover, IL-33 can play both pro-tumor and anti-tumor roles in the same type of tumor.

    Citation

    Qianqian Liu, Di Lu, Jiahua Hu, Junchao Liang, Huoying Chen. Dual role of interleukin-33 in tumors. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 2021 Feb 28;46(2):169-175

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33678654

    View Full Text